Pfizer financial analysis

2165 words 9 pages
Show More
217741531115000 Pfizer Inc. Financial Analysis (2011-2013)
Table of Content
General comments………………………………………………………………………………………………………………………………….2
Comments on financial ratios……………………………………………………………………………….…………………………….….3
Profitability indicator ratios…………………………………………………………………………………………………….….……………3
Liquidity Measurement ratios…………………………………………………………………………………………………….…………..4
Efficiency ratios……………………………………………………………………………………………………………………..….………….…5
Capital structure………………………………………………………………………………………………………………………….………….5
Investment ratio………………………………………………………………………………………………………………………….………….6
Conclusions………………………………………………………………………………………………………………………………….…..…….6
References………………………………………………………………………………………………………………………………………………8
General …show more content…

The operating margin of Pfizer has grown, due to reduction of R&D, SG&A (in particularly workforce reduction from 91,500 to 77,700 in 2013) by global cost-reduction/productivity initiatives through applying various forms of business development, which includes alliances, licenses, joint ventures, dispositions and acquisitions5, and can be estimated as a good strategy to future performance.
Quite high level of return on sales in 2013 (42.7%) compared to 26.7% in 2012 caused essentially by gain on sales of discontinued operations – disposal of Animal Health business with recognizing a gain of approximately $10.3 billion net of tax.
ROA ratio can be very useful for potential investors in the pharmaceutical industry, highly dependent on assets as function of R&D sites. ROA ratio demonstrates that Pfizer belongs to capital intensive business; money that company generates on invested capital is below of an industry average, which makes it negative to an investment decision. However, in 2013 ROA has significantly increased (approx. for 3%) compared to 2012 primary due to disposal of assets of discontinued operations and insignificantly due to increased operating income, which makes ROA growth look unconvincing.
ROCE ratio shows profitability increase which means Pfizer did a better job deploying its working capital in 2013, another words, with less of CE (2012 - $156 billion, 2012 - $143

Related

  • Pfizer Financial Analysis
    1346 words | 6 pages

    Pfizer Incorporated (PFE) was established in 1849 in Brooklyn, New York. Charles Pfizer and Charles Erhardt, two German-American cousins, founded a chemicals business and produced an anti-parasitic- Santorin, which was a great success.Pfizer's business began to grow with production of citric acid in 1880s. Total sales of Pfizer had reached almost $3 million by 1910. By 1950s, Pfizer had set up business in countries like Belgium, Canada, Iran, Panama, Turkey, and United Kingdom. Pfizer is a pharmaceutical….

    Show More
  • Pfizer Case Study
    5210 words | 21 pages

    Pfizer – Written Case Report Prepared by: BAMG 456-023: Strategic Management & Business Policy (Fall 2012) Table of Contents: 1. Part One: Evaluation of the External Environment a. Introduction 4 b. Opportunities and Threats 6 i. Assessment of Societal (Remote) Environment ii. Assessment of Industry (Task) Environment iii. Assessment of Competition (Bryan Jenkins) iv. Overall Opportunities and Threats and Score 2….

    Show More
  • Pfizer Case Study
    1490 words | 6 pages

    Question 1: Describe and evaluate what Pfizer is doing? Pfizer is the world’s largest research-based pharmaceuticals firm and also a well known Pharmaceutical company. So their most of the work depends on research, developing Strategies and innovate. They were trying to find a new way of system which makes their Work more effective and efficient. Pfizer find out that their worker spends more time on Business research and data analysis to the creation of documents and other routine Support like….

    Show More
  • Pfizer Marketing Plan
    9811 words | 40 pages

    following marketing plan will focus on how Pfizer, the leading company in the pharmaceutical industry will perform in tough competition conditions. A brief introduction of the field of pharmaceutical will be highlighted along with a short introduction about the company and its history. A market analysis will be performed to study the different factors affecting the pharmaceutical industry as a whole and our company specifically. The market analysis will give us a clear idea about where we stand….

    Show More
  • The Glbal Phamaceutical Industry
    1587 words | 7 pages

    19852274 Assignment Title : The Global Pharmaceutical Industry. Date : 10 March 2012 Programme : BTECH-MANAGEMENT IV Question 1 Identify the main environmental forces currently affecting the global pharmaceutical industry? PESTEL analysis of the global pharmaceutical industry: Political * Governments set stringent regulation and is a powerful purchaser. * Governments around the world focus on pharmaceuticals as a politically easy target in their efforts to control rising….

    Show More
  • Paper - Wyeth
    1861 words | 8 pages

    value to Pfizer. The main question to address is to understand how the products at Wyeth fit within Pfizer’s capabilities and which business segments, more specifically which pharmaceuticalceutical segments, could Pfizer leverage to achieve economies of scope from the acquisition of Wyeth. To consider how the two product portfolios coalesce, it is critical to examine Pfizer’s pharmaceuticalceutical pipeline in 2008, prior to the Wyeth acquisition. Exhibit 3 shows the categories which Pfizer used to….

    Show More
  • Merck Case Study
    6947 words | 28 pages

    operations of Merck & Co. Inc. and determine areas of potential concern, evaluate the effectiveness of the current business model, and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity, offer solutions, and make projections based upon historic data related to Merck and its competitors. The information utilized will be derived from sales figures, patents….

    Show More
  • Advanced Accounting Chapter 8
    6718 words | 27 pages

    three criteria. 1. Engage in business activities and earn revenues and incur expenses. 2. Operating results are regularly reviewed by the chief operating decision-maker to assess performance and make resource allocation decisions. 3. Discrete financial information is available….

    Show More
  • Kelo vs. City of New London
    2221 words | 9 pages

    Kelo vs. City of New London Legal Facts: Kelo v. City of New London 545 U.S. 469 (2005) the U.S. Supreme Court answered “yes” to the question of whether or not taking land for the sole purpose of economic improvement would fall into the realm of public use requirement set forth in the Fifth Amendment’s Takings Clause. The city of New London Connecticut had made economic recovery efforts to sustain a severely downtrodden local economy. Those efforts included a plan to acquire 115 parcels of….

    Show More
  • Investment Analysis and Portfolio Management
    2241 words | 9 pages

    Investment Analysis and Portfolio Management Date: May 18, 2011 | 1. Impact of various causative factors on the three indicators: According to the observation of the past one-month, it infers that DJIA and NASDAQ Index fluctuate to grow, and 10-year Treasury Note Yield fell down. After analyze the daily causative factors, I find several parts influence the indicators. Most of all, the whole economic trend is the most important impact of various causative factors. The three indicators are all….

    Show More

Popular Essays